Rita S. C.
- Country
- Belgium
- Department
- Oncology
Research Overview
- Evaluation of Short-Course Radiotherapy Versus Total Neoadjuvant Therapy in Elderly Patients with Locally Advanced Rectal Cancer: A Randomized Clinical Trial
- Phase I/Ib Open-Label Study of OBT076 and Balstilimab in Recurrent/Metastatic CD205-Positive Solid Tumors
- Phase II Study of Neoadjuvant Regorafenib and Nivolumab with Short-Course Radiotherapy in Intermediate-Risk Stage II-III Rectal Cancer
Data & Insights
Has run more than one trial at 9 of 35 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in treating advanced forms of gastric cancer and gastroesophageal junction adenocarcinoma, with particular emphasis on innovative therapeutic approaches for these aggressive malignancies.
- Advanced Gastric Cancer Management
- Gastroesophageal Junction Tumors
- Pancreatic Adenocarcinoma Treatment
Focuses on developing targeted therapies and exploring novel drug combinations for gastrointestinal malignancies.
Colorectal Cancer Research
Investigates advanced treatment strategies for locally advanced rectal cancer, with specific attention to age-adapted therapeutic approaches and neoadjuvant treatment modalities.
- Neoadjuvant Therapy Optimization
- Short-Course Radiotherapy Applications
- Stage II-III Rectal Cancer Treatment
Specializes in personalized treatment approaches for different patient populations with rectal cancer.
Immunotherapy Integration
Explores the application of immunotherapy combinations across multiple tumor types, including integration with conventional cancer treatments and novel therapeutic agents.
- Pan-tumor Treatment Strategies
- Combined Modality Approaches
- Long-term Safety Assessment
Studies long-term outcomes and safety profiles of immunotherapy treatments in various cancer settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.